IRCT20160523028008N16尚未招募2 期
Evaluation of the effectiveness of doxycycline in the treatment of outpatients with Covid-19 .
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Minimum age 18 and maximum age 80 years
- •Do not take doxycycline for the last five days
- •Patients with definitive diagnosis of Covid 19 (RT-PCR) candidate for outpatient treatment with pulmonary involvement score on CT scan equal to or below 8
- •Patients suspected of Covid-19 based on clinical signs and manifestations of CT scan and laboratory results candidate for outpatient treatment.
排除标准
- •Hospitalization
- •Patients with no indications for outpatient treatment based on national protocol.
- •Patients with a history of allergic reaction or Doxycycline.
- •Underlying disease
研究者
相似试验
尚未招募
2 期
Treatment of periodontal defects with a combination of autologous blood products and antibioticsCTRI/2024/07/070193DOGIPARTHI MOUNICA
已完成
不适用
The effect of doxycycline and zinc sulfate in acneacne vulgaris.Disease of skin appendagesIRCT201105156493N1Tabriz University of Medical Sciences80
已完成
不适用
Clinical effects of subantimicrobial dose doxycyclineIRCT201205058205N2Vice chancellor for research, Shahid Sadoghi University of Medical Sciences44
已完成
2 期
A clinical trial to study the effect of doxycycline in patients of chronic obstructive pulmonary disease with stable symptomsCTRI/2011/091/000042Govt Medical College72
进行中（未招募）
不适用
Efficacité et tolérance de la doxycycline dans le traitement des maladies humaines à prions : un essai randomisé en double aveugle versus placebo - DOXYPRIONSEUCTR2007-005553-34-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)